Education
About Us
Working with TipRanks
Follow Us
Bicara Therapeutics Inc. (BCAX)
NASDAQ:BCAX
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -82.39M | $ -39.89M | $ -37.66M |
| EBITDA | $ -82.39M | $ -51.96M | $ -37.72M |
| Net Income | $ -68.00M | $ -51.98M | $ -37.84M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 489.71M | $ 230.44M | $ 4.16M |
| Total Assets | $ 510.00M | $ 233.98M | $ 6.70M |
| Total Debt | $ 738.00K | $ 657.00K | $ 0.00 |
| Net Debt | $ -488.97M | $ -229.78M | $ -4.16M |
| Total Liabilities | $ 18.12M | $ 382.75M | $ 105.51M |
| Stockholders' Equity | $ 491.88M | $ -148.77M | $ -98.80M |
| Cash Flow | |||
| Free Cash Flow | $ -74.82M | $ -46.21M | $ -32.27M |
| Operating Cash Flow | $ -74.75M | $ -45.63M | $ -32.08M |
| Investing Cash Flow | $ -9.00K | $ -586.00K | $ -192.00K |
| Financing Cash Flow | $ 334.03M | $ 272.50M | $ 31.70M |